This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Addex Therapeutics Ltd
Q12023
5/11/2023
Conference Call Operator
Operator
23 financial results and corporate update at this time all participants are in a listen only mode after the speaker's presentation there will be a question and answer session to ask a question during the session you will need to press star 1 1 on your telephone you will then hear an automated message advising your hand is raised to withdraw your question please press star 1 1 again to ask a question via the webcast please access the ask a question tab please be advised that today's conference is being recorded I would now like to hand the conference over to your speaker today, Tim Dyer.
Tim Dyer
Company Executive (Speaker)
Hello, everyone. I would like to thank you all for attending our first quarter 2023 financial results conference call. I'm here with Robert Lugens, our head of discovery biology. I draw your attention to the press release and the financial statements issued earlier today, which are available on our website. I also draw your attention to our disclaimer. We will be making certain forward-looking statements that are based on the knowledge we have today.
Unknown
Unknown (Brief remark with no identifying details)
I will then review our Q1 2023 financial results. Following that, we will
You're reading a preview of the ADXN Q1 2023 earnings call.
Free account.
Disclaimer